FCM
TXMD icon

Frontier Capital Management’s TherapeuticsMD TXMD Stock Holding History

Frontier Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-128,230
Closed -$15.5M – 291
2019
Q4 		$15.5M Buy
128,230
+13,250
+12% +$1.91M 0.11% 198
2019
Q3 		$20.9M Sell
114,980
-19,666
-15% -$2.77M 0.16% 165
2019
Q2 		$17.5M Buy
134,646
+17,504
+15% +$3.14M 0.13% 181
2019
Q1 		$28.5M Buy
117,142
+87,219
+291% +$23.1M 0.2% 158
2018
Q4 		$5.7M Buy
+29,923
New +$7.3M 0.05% 259

Other funds holding TXMD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return